-Approximately 500 Canadians ages 6-11 are now eligible for TRIKAFTA®- -Vertex has submitted this indication to CADTH & INESSS for Health Technology Assessments- BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today anno
Data show PKMYT1 inhibition is a promising therapeutic target in CCNE1-amplified cancers RP-6306, a first-in-class, oral PKMYT1 inhibitor, is currently being evaluated in Phase 1 clinical trials CAMBRIDGE, Mass. & MONTREAL--(BUSINESS WIRE)--Repare Thera
IPA's PolyTope® TATX-03 shows continuous validation of potent in vitro neutralizing activity against SARS-CoV-2 variants of concern, as further demonstrated against the Omicron sublineage BA.2 Neutralization potency of the TATX-03 cocktail towards BA
BURLINGTON, Ontario--(BUSINESS WIRE)--Anaergia Inc. (“Anaergia” or the “Company”) (TSX: ANRG), a company created to eliminate greenhouse gases by cost-effectively turning organic waste into renewable natural gas, fertilizer, and water, by offering
VANCOUVER, British Columbia & SEATTLE--(BUSINESS WIRE)--Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that management will report its first quarter 2022 financial result
DUBLIN--(BUSINESS WIRE)--The "Efficacy Testing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Efficacy Testing Market to Reach $796.7 Million by 2026 The global market for Efficacy Testing
Ambu expands its addressable market by supporting FEES procedures. COLUMBIA, Md.--(BUSINESS WIRE)--Ambu continues to advance the market for single-use endoscopy by addressing Fibreoptic Endoscopic Evaluation of Swallowing (FEES). FEES is an imaging proce
Not for Distribution in the United States or Over United States News Wire Services BURLINGTON, Ontario--(BUSINESS WIRE)--Anaergia Inc. (“Anaergia” or the “Company”) (TSX: ANRG) today announced the closing of its previously announced bought deal o
VANCOUVER, British Columbia--(BUSINESS WIRE)--#ScientificAdvisoryBoard--Gandeeva Therapeutics, a precision biotechnology company harnessing the power of cryogenic electron microscopy (cryo-EM) and machine learning to develop novel therapeutics at an accel
• Monday, May 2 at 11:00 a.m. ET • MISSISSAUGA, Ontario--(BUSINESS WIRE)--Nuvo Pharmaceuticals® Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused healthcare company with global reach and a diversified po
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.